Management of hepatocellular carcinoma recurrence after liver transplant is far from perfect

被引：2
|
作者：
Mancuso, Andrea [1 ]
Maringhini, Alberto [1 ]
机构：
[1] Azienda Rilievo Nazl Alta Specializzaz Civ Di Cri, Med Interna 1, Piazzale Leotta 4, I-90100 Palermo, Italy
来源：
AMERICAN JOURNAL OF SURGERY | 2018年 / 216卷 / 02期
关键词：
Hepatocellular carcinoma; Recurrence; Sorafenib; Liver transplant; SORAFENIB TREATMENT; EFFICACY; SURVIVAL; SAFETY; TIME; COMBINATION; EVEROLIMUS;
D O I：
10.1016/j.amjsurg.2017.04.004
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [31] BMI AS A PREDICTOR OF HEPATOCELLULAR CARCINOMA RECURRENCE IN LIVER TRANSPLANT PATIENTS
    Higley, Cory
    Abaza, Ehab
    Hsu, Christine C.
    HEPATOLOGY, 2020, 72 : 689A - 690A
  • [32] Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
    Au, Kin Pan
    Chok, Kenneth Siu Ho
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (45) : 5081 - 5094
  • [33] Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
    Kin Pan Au
    Kenneth Siu Ho Chok
    World Journal of Gastroenterology, 2018, 24 (45) : 5081 - 5094
  • [34] Validation of Risk Estimation of Tumor Recurrence After Transplant Score in Patients With Hepatocellular Carcinoma Treated by Liver Transplant
    Abdelfattah, Mohamed R.
    El-Haddad, Hani Mostafa
    Elsiesy, Hussein
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (12) : 1298 - 1302
  • [35] Adrenalectomy for Bilateral Metachronous Adrenal Recurrence of Hepatocellular Carcinoma After Liver Transplant: A Case Report
    Mikulic, Danko
    Stironja, Ivan
    Jadrijevic, Stipislav
    Skrtic, Anita
    Mrzljak, Anna
    Kanizaj, Tajana Filipec
    Kocman, Branislav
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (03) : 407 - 409
  • [36] Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence after Liver Transplant.
    Hendon, N.
    Salerno, D.
    Sammons, C.
    Halazun, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 723 - 723
  • [37] Predictive Factors for the Resectable Type of Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplant
    Kurihara, Takeshi
    Harada, Noboru
    Morinaga, Akinari
    Tomiyama, Takahiro
    Toshida, Katsuya
    Kosai, Yukiko
    Tomino, Takahiro
    Toshima, Takeo
    Nagao, Yoshihiro
    Morita, Kazutoyo
    Itoh, Shinji
    Yoshizumi, Tomoharu
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (01) : 191 - 196
  • [38] Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant
    Pagano, Duilio
    Barbera, Floriana
    Conaldi, Pier Giulio
    Seidita, Aurelio
    Di Francesco, Fabrizio
    Di Carlo, Daniele
    Barbara, Marco
    Tuzzotino, Fabio
    Luca, Angelo
    Gruttadauria, Salvatore
    ANNALS OF TRANSPLANTATION, 2019, 24 : 223 - 233
  • [39] Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation
    Lao, Oliver B.
    Weissman, Jennifer
    Perkins, James D.
    CLINICAL TRANSPLANTATION, 2009, 23 (06) : 874 - 881
  • [40] Reply to: Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant
    Cholongitas, Evangelos
    Burra, Patrizia
    TRANSPLANT INTERNATIONAL, 2015, 28 (04) : 503 - 504
12345